245 related articles for article (PubMed ID: 2578065)
1. Immunotherapy in genitourinary neoplasia.
Droller MJ
J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
[No Abstract] [Full Text] [Related]
2. Immunotherapy in genitourinary neoplasia.
Droller MJ
Urol Clin North Am; 1984 Nov; 11(4):643-57. PubMed ID: 6209844
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy and genitourinary neoplasia.
Droller MJ
Urol Clin North Am; 1980 Oct; 7(3):831-46. PubMed ID: 6161466
[No Abstract] [Full Text] [Related]
4. Novel immunotherapies in GU malignancies.
Drakaki A; McDermott DF
Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
[TBL] [Abstract][Full Text] [Related]
5. [Trials of immunotherapy in tumors of the urinary tract].
Corrado F; Pizza G
Arch Esp Urol; 1984 Dec; 37 Suppl 2():659-66. PubMed ID: 6336141
[No Abstract] [Full Text] [Related]
6. Immunologic features of genitourinary cancer.
Javadpour N
Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
[No Abstract] [Full Text] [Related]
7. [Immunology of malignant neoplasms of the urogenital system].
Stratev S
Khirurgiia (Sofiia); 1988; 41(1):46-52. PubMed ID: 3285081
[No Abstract] [Full Text] [Related]
8. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
Bigot F; Bonnet C; Massard C
Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
[TBL] [Abstract][Full Text] [Related]
9. Immunologic therapies of kidney carcinoma.
McCune CS
Semin Oncol; 1983 Dec; 10(4):431-6. PubMed ID: 6198729
[No Abstract] [Full Text] [Related]
10. An Overview of Emerging Immunotargets of Genitourinary Tumors.
Montironi R; Santoni M; Cheng L; Lopez-Beltran A; Massari F; Matrana MR; Moch H; Scarpelli M
Curr Drug Targets; 2016; 17(7):750-6. PubMed ID: 26648079
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of superficial bladder cancer.
Shapiro A; Kadmon D; Catalona WJ; Ratliff TL
J Urol; 1982 Nov; 128(5):891-4. PubMed ID: 6184490
[No Abstract] [Full Text] [Related]
12. Biologic response modifiers in genitourinary neoplasia.
Droller MJ
Cancer; 1987 Aug; 60(3 Suppl):635-44. PubMed ID: 2439187
[TBL] [Abstract][Full Text] [Related]
13. Genitourinary cancer.
Hudes GR; Grana G; Deshields MS; Ozols RF
Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
[No Abstract] [Full Text] [Related]
14. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
[No Abstract] [Full Text] [Related]
15. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
[No Abstract] [Full Text] [Related]
16. The role of immunotherapy for urological tumours.
Hrouda D; Muir GH; Dalgleish AG
Br J Urol; 1997 Mar; 79(3):307-16. PubMed ID: 9117206
[No Abstract] [Full Text] [Related]
17. Immunology of genitourinary tumors.
Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
[No Abstract] [Full Text] [Related]
18. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
19. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
20. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
Catalona WJ; Chretien PB; Trahan EE
J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
